GlobalGov › Germany › Solicitation

Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren

IKK Classic · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

July 05, 2028
Response Due
Active
Status

Opportunity Overview

Aclidiniumbromid; ATC-Code: R03BB05 | Anakinra; ATC-Code: L04AC03 | Brivaracetam; ATC-Code: N03AX23 | Chinin; ATC-Code: P01BC01 (WHO), M09AA02 (ADV) | Darbepoetin; ATC-Code: B03XA02 | Dexamfetamin; ATC-Code: N06BA02 | Epoetin beta; ATC-Code: B03XA01 | Epoetin theta; ATC-Code: B03XA01 | Felodipin und Ramipril; ATC-Code: C09BB05 | Golimumab; ATC-Code: L04AB06 | Hydrocortison; ATC-Code: H02AB09 | Methylprednisolonaceponat; ATC-Code: D07AC14 | Minoxidil; ATC-Code: C02DC01 | Naloxegol; ATC-Code: A06AH03 | Ocrelizumab; ATC-Code: L04AG08 | Paliperidon; Depot-Injektionssuspension; Wirkstärke ab 175 mg; ATC-Code: N05AX13 | PEG-Epoetin beta; ATC-Code: B03XA03 | Perampanel; ATC-Code: N03AX22 | Perindopril, Amlodipin und Indapamid; ATC-Code: C09BX01 | Ranibizumab; Durchstechflaschen; ATC-Code: S01LA04 | Ranibizumab; Fertigspritzen; ATC-Code: S01LA04 | Teduglutid; ATC-Code: A16AX08 | Thalidomid; ATC-Code: L04AX02 | Formoterol, Glycopyrroniumbromid und Budesonid; ATC-Code: R03AL11

This Germany Pharmaceuticals opportunity is one most of your competitors will never see.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start a free GlobalGov account

Solicitation Details

Issuing agencyIKK Classic
CountryGermany
CategoryPharmaceuticals
PublishedAugust 31, 2026
Procurement stageRequest for Proposal (RFP)
Response dueJuly 05, 2028
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Browse all categories →

Related Opportunities in Germany

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Denosumab, ATC M05BX04
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff FAM OLIMEL (ausgenommen elektrolytfrei;7,6 %; KPG) + austauschbare FAM, ATC B05BA10 f. d. Z. 1.10.26-30.09.28
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Atomoxetin, ATC N06BA09
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Follitropin alfa (ATC: G03GA05)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Mesalazin, ATC A07EC02
Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-15
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-05 - Emtricitabin/Tenofovirdisoproxil/Rilpivirin (Wirkstoffkombination)
Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-08

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.